Kazia Therapeutics Ltd ADR (KZIA) — Cash Flow Quality Index
Kazia Therapeutics Ltd ADR (KZIA) has a Cash Flow Quality Index of -18.50x as of December 2017. Operating cash flow of $-7.86 Million is below net income of $424.78K, suggesting accrual-heavy earnings not yet converted to cash. Explore Kazia Therapeutics Ltd ADR strategic investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Kazia Therapeutics Ltd ADR Cash Flow Quality Index (2000–2012)
Historical Cash Flow Quality Index for Kazia Therapeutics Ltd ADR across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Kazia Therapeutics Ltd ADR (KZIA) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Kazia Therapeutics Ltd ADR (2000–2012)
Year-by-year earnings quality comparison for Kazia Therapeutics Ltd ADR. For live market cap and the full company financial profile, see market value of Kazia Therapeutics Ltd ADR.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2012 | -5.61x | $-7.35 Million | $1.31 Million | ▼ -550.5% |
| 2000 | -0.86x | $-18.75 Million | $21.73 Million | — |